Clinical Trial

The Burden of Lupus in Canada From a Patient Perspective: A Canadian Real-World PROxy Study

Completed
View on ClinicalTrials.gov →
Summary
This study aims to capture the Canadian patient experience, burden, barriers, and treatment preferences. The findings will generate real-world evidence to support patient-centered care and guide healthcare providers, researchers, and decision-makers in improving support and treatment for people living with lupus.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2025-11-24; most recent amendment 2026-01-27.
Status change: Enrolling by Invitation → Completed 2026-01-27
Trial Details
NCT Number NCT07267091
Lead Sponsor PeriPharm
Conditions Lupus, Lupus Arthritis, Lupus Arthritis, Systemic Lupus Erythematosus, Quality of Life (QOL)
Enrollment 88 participants
Start Date 2025-11-03
Primary Completion 2026-01-23 (estimated)
Study Completion 2026-01-23 (estimated)
Updated on ClinicalTrials.gov 2026-01-29